High level of circulating cell-free tumor DNA at diagnosis correlates with disease spreading and defines multiple myeloma patients with poor prognosis.
Martello M, Solli V, Mazzocchetti G, Solimando AG, Bezzi D, Taurisano B, Kanapari A, Poletti A, Borsi E, Armuzzi S, Vigliotta I, Pistis I, Desantis V, Marzocchi G, Rizzello I, Pantani L, Mancuso K, Tacchetti P, Testoni N, Nanni C, Zamagni E, Cavo M, Terragna C.
Martello M, et al. Among authors: desantis v.
Blood Cancer J. 2024 Nov 28;14(1):208. doi: 10.1038/s41408-024-01185-6.
Blood Cancer J. 2024.
PMID: 39609411
Free PMC article.